Mankind Pharma Completes Landmark Acquisition of BSV Learn More
Annual Report
Investor Centre

Annual Report

REVENUE
₹ 12,207 Cr
Adj. EBITDA
₹ 3,159 Cr
PAT
₹ 2,007 Cr
Annual Reports
FY2024-25
FY2023-24
FY2022-23
FY2021-22
FY2020-21
FY2019-20

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Financials of Subsidiaries
FY2024-25
FY2023-24
FY2022-23

Loading...

Loading...

Loading...